Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01689441 · ClinicalTrials.gov registry record · Phase 2
Randomized Controlled Trial of Calcitriol vs. Placebo Among Critically-ill Patients With Sepsis
A Phase 2 study of Severe Sepsis or Septic Shock, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 67
- Enrollment target
- 1
- Study location
NCT01689441 is a Phase 2 study of Severe Sepsis or Septic Shock that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 67 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01689441, a Phase 2 study of Severe Sepsis or Septic Shock, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 67 participants
- Enrollment target
- 1
- Study location
Study Summary
Observational studies among critically ill patients have shown strong associations between vitamin D deficiency and adverse outcomes, including increased length of stay, infection, and mortality. It is unknown whether vitamin D deficiency contributes directly to adverse outcomes or whether it is simply a biomarker of severity of illness or overall health status. However, vitamin D plays a key role in host defense, largely by stimulating production of the anti-microbial peptide cathelicidin (LL-37). We will test the hypothesis that administration of activated vitamin D (calcitriol) will increase serum levels of cathelicidin.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Calcitriol
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2013-02 |
| Est. Completion | 2014-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01689441
The ClinicalTrials.gov registry entry for NCT01689441 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Severe Sepsis or Septic Shock appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01689441 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01689441 about?
NCT01689441 is a clinical study titled "Randomized Controlled Trial of Calcitriol vs. Placebo Among Critically-ill Patients With Sepsis". Observational studies among critically ill patients have shown strong associations between vitamin D deficiency and adverse outcomes, including increased length of stay, infection, and mortality. It is unknown whether vitamin D deficiency contributes directly to adverse outcomes or whether it is sim...
What is the current status of trial NCT01689441?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 67 participants. The study started on 2013-02. Estimated completion is 2014-02.
What conditions does trial NCT01689441 study?
This clinical trial studies the following conditions: Severe Sepsis or Septic Shock.
What interventions are being tested in trial NCT01689441?
The interventions under investigation include: Placebo (DRUG), Calcitriol (DRUG).
Who is sponsoring clinical trial NCT01689441?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01689441 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.